prednisolone has been researched along with Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodis, DG | 1 |
| Liatsos, GD | 1 |
| Moulakakis, A | 1 |
| Pirounaki, M | 1 |
| Tasidou, A | 1 |
1 other study available for prednisolone and Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
| Article | Year |
|---|---|
Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases, Metabolic; Cerebellar Ataxia; | 2009 |